Before you start, get your bearings.

A starting checklist for the decision.

• Put your goal into ordinary words.

  Are you seeking help with weight, blood sugar, or another health concern? Tell the health professional what brought you here.

  Semaglutide (Ozempic, Wegovy, Rybelsus) copies a hormone from the gut, a body signal that helps manage blood sugar and appetite.

  As of September 26, 2026, Wegovy was approved for weight care; Ozempic’s approved uses were for adults with type 2 diabetes.

• Understand what an online visit changes.

  With telehealth, care takes place over video, on the phone or through an exchange online, without patient and professional sharing a room.

  A controlled medicine is a drug subject to extra rules because it can be misused.

  On September 26, 2026, an in-person visit was not a federal legal requirement for prescribing a non-controlled medicine such as semaglutide.

  State rules still apply, and an online visit does not guarantee a prescription.

  Medical-board guidance requires the same care standards for online visits and visits in person.

  Ask how the person treating you will get enough information to decide whether the medicine fits you.

• Choose the setting that lets you ask questions.

  Compare licensed online care with an in-person clinic. Ask how an online service handles a need for tests or a physical exam.

  Under medical-board guidance, the treating professional must arrange in-person tests or an examination when those are needed to assess your health.

• Leave room for an answer other than yes.

  Ask what other options fit your goal, and what the next step would be if semaglutide does not fit. A visit can be useful without ending in a prescription.